Short-term relugolix treatment for fibroid-related pain: where do we go from here?
Volume 112, Issue 5, Pages 819–820
Paolo Vercellini, M.D.a,b, Giussy Barbara, M.D.a, Edgardo Somigliana, M.D.a,b
Reflections on "Relugolix. A novel oral GnRH antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo controlled, phase 3 study in Japanese women" by Osuga et al.